By Dr. David Edward Marcinko MBA MEd
***
***
⚠️ Cons of Compounding Pharmacies
1. Quality and Safety Concerns
- Medications are not FDA-approved, meaning they don’t go through the same rigorous testing as commercial drugs.
- Risk of contamination or incorrect formulation if strict standards aren’t followed.
- Potency can vary between batches, leading to inconsistent therapeutic effects.
2. Limited Regulation
- Oversight is less stringent compared to mass-produced pharmaceuticals.
- Standards may differ depending on the state or the specific pharmacy.
- Patients may not always know whether their compounding pharmacy meets high-quality benchmarks.
3. Insurance and Cost Issues
- Compounded medications are often not covered by insurance.
- They can be more expensive due to customization and small-scale production.
4. Availability and Accessibility
- Not all pharmacies offer compounding services.
- Patients may need to travel farther or wait longer to receive their medication.
***
***
5. Evidence and Efficacy
- Limited clinical trials or scientific evidence supporting compounded formulations.
- Effectiveness may rely heavily on anecdotal reports rather than standardized studies.
6. Risk of Errors
- Human error in measuring, mixing, or labeling can lead to incorrect dosages.
- Lack of standardized packaging may increase confusion for patients.
👉 In short: while compounding pharmacies can provide personalized solutions, the downsides include less regulation, higher costs, safety risks, and limited evidence of efficacy compared to FDA-approved medications.
COMMENTS APPRECIATED
SPEAKING: Dr. Marcinko will be speaking and lecturing, signing and opining, teaching and preaching, storming and performing at many locations throughout the USA this year! His tour of witty and serious pontifications may be scheduled on a planned or ad-hoc basis; for public or private meetings and gatherings; formally, informally, or over lunch or dinner. All medical societies, financial advisory firms or Broker-Dealers are encouraged to submit an RFP for speaking engagements: CONTACT: Ann Miller RN MHA at MarcinkoAdvisors@outlook.com -OR- http://www.MarcinkoAssociates.com
Like, Subscribe and Refer
***
***
Filed under: "Doctors Only", Drugs and Pharma, Ethics, Health Law & Policy, iMBA, Inc., Marcinko Associates | Tagged: compounding pharmacy, costs, david marcinko, DEA, Drugs, FDA, health, healthcare, medicine, pharmacist, prescriptions, quality, Rx, safety, Technology | Leave a comment »














